Characteristics | No. of patients | Percent(%) |
---|---|---|
Age, years | ||
Median(range) | 52(32–71) | |
Menopausal status | ||
Postmenopausal | 21 | 65.63% |
Premenopausal | 11 | 34.37% |
ER | ||
+ | 16 | 50.00% |
- | 16 | 50.00% |
PR | ||
+ | 9 | 28.13% |
- | 23 | 71.87% |
HER2 | ||
+ + | 8 | 25.00% |
+ + + | 24 | 75.00% |
Primary and Metastatic sites | ||
Breast | 17 | 53.13% |
Lung | 12 | 37.50% |
Liver | 8 | 25.00% |
Bone | 14 | 43.75% |
Viscera | 25 | 78.13% |
Lymph node | 29 | 90.63% |